Literature DB >> 7492780

The insulin receptor substrate-1-related 4PS substrate but not the interleukin-2R gamma chain is involved in interleukin-13-mediated signal transduction.

L M Wang1, P Michieli, W R Lie, F Liu, C C Lee, A Minty, X J Sun, A Levine, M F White, J H Pierce.   

Abstract

Interleukin-13 (IL-13) induced a potent mitogenic response in IL-3-dependent TF-1 cells and DNA synthesis to a lesser extent in MO7E and FDC-P1 cells. IL-13 stimulation of these lines, like IL-4 and insulin-like growth factor-1 (IGF-1), resulted in tyrosine phosphorylation of a 170-kD substrate. The tyrosine-phosphorylated 170-kD substrate strongly associated with the 85-kD subunit of phosphoinositol-3 (PI-3) kinase and with Grb-2. Anti-4PS serum readily detected the 170-kD substrate in lysates from both TF-1 and FDC-P1 cells stimulated with IL-13 or IL-4. These data provide evidence that IL-13 induces tyrosine phosphorylation of the 4PS substrate, providing an essential interface between the IL-13 receptor and signaling molecules containing SH2 domains. IL-13 and IL-4 stimulation of murine L cell fibroblasts, which endogenously express the IL-4 receptor (IL-4R alpha) and lack expression of the IL-2 receptor gamma subunit (IL-2R gamma), resulted in tyrosine phosphorylation of insulin receptor substrate-1 (IRS-1)/4PS. Enhanced tyrosine phosphorylation of IRS-1/4PS was observed in response to IL-4, but not IL-13 treatment of L cells transfected with the IL-2R gamma chain. These results indicate that IL-13 does not use the IL-2R gamma subunit in its receptor complex and that expression of IL-2R gamma enhances, but is not absolutely required for mediating IL-4-induced tyrosine phosphorylation of IRS-1/4PS.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7492780

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  7 in total

1.  Interleukin-13 is a potent activator of JAK3 and STAT6 in cells expressing interleukin-2 receptor-gamma and interleukin-4 receptor-alpha.

Authors:  M G Malabarba; H Rui; H H Deutsch; J Chung; F S Kalthoff; W L Farrar; R A Kirken
Journal:  Biochem J       Date:  1996-11-01       Impact factor: 3.857

2.  Preparation of a recombinant chimaera of insulin-like growth factor II and interleukin 3 with high proliferative potency for haemopoietic cells.

Authors:  M R Difalco; L F Congote
Journal:  Biochem J       Date:  1997-09-01       Impact factor: 3.857

3.  Interleukin-4-specific signal transduction events are driven by homotypic interactions of the interleukin-4 receptor alpha subunit.

Authors:  S Y Lai; J Molden; K D Liu; J M Puck; M D White; M A Goldsmith
Journal:  EMBO J       Date:  1996-09-02       Impact factor: 11.598

4.  The extracellular and transmembrane domains of the γC and interleukin (IL)-13 receptor α1 chains, not their cytoplasmic domains, dictate the nature of signaling responses to IL-4 and IL-13.

Authors:  Nicola M Heller; Xiulan Qi; Franck Gesbert; Achsah D Keegan
Journal:  J Biol Chem       Date:  2012-07-24       Impact factor: 5.157

5.  Interleukin-13 exerts autocrine growth-promoting effects on human pancreatic cancer, and its expression correlates with a propensity for lymph node metastases.

Authors:  Andrea Formentini; Olga Prokopchuk; Joern Sträter; Joerg Kleeff; Lukasz Filip Grochola; Gerd Leder; Doris Henne-Bruns; Murray Korc; Marko Kornmann
Journal:  Int J Colorectal Dis       Date:  2008-08-31       Impact factor: 2.571

Review 6.  Phosphoinositide 3-kinase: the key switch mechanism in insulin signalling.

Authors:  P R Shepherd; D J Withers; K Siddle
Journal:  Biochem J       Date:  1998-08-01       Impact factor: 3.857

7.  Irs2 and Irs4 synergize in non-LepRb neurons to control energy balance and glucose homeostasis.

Authors:  Marianna Sadagurski; X Charlie Dong; Martin G Myers; Morris F White
Journal:  Mol Metab       Date:  2013-10-23       Impact factor: 7.422

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.